How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia? - Publication - Bridge of Knowledge

How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?

Abstract

Citations

0

CrossRef
0

Web of Science
0

Scopus

Authors (2)

Aleksander Salomon-Perzyński
Bożena Budziszewska

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: Hematology in Clinical Practice no. 14, edition 0, pages 6 - 10,
ISSN: 2720-1015
ISSN:: 2720-1015
Publication year:: 2023
DOI:: Digital Object Identifier (open in new tab) 10.5603/hcp.2023.0002
Verified by:: No verification

seen 24 times